ILUMINA
- Illumina was named to the 100 Best Corporate Citizens list for its efforts in business ethics, product responsibility, and social impact.
- The company announced the launch of Illumina Protein Prep, a new product combining aptamer assays and next-generation sequencing for proteomics research.
- The launch of the new MiSeq i100 alongside the Pillar OncoReveal panels is part of expanded partnerships in cancer care.
- The company announced the launch of Illumina Protein Prep, a new product combining aptamer assays and next-generation sequencing for proteomics research.
- A new State-of-the-Art Solution Center was established in Latin America to expand access to genomics.
- The company is partnering with Alnylam and NashBio to accelerate drug discovery processes.
- A new State-of-the-Art Solution Center was established in Latin America to expand access to genomics.
- Illumina staff are involved in a fundraising milestone for Pedal the Cause, supporting cancer research.
- The company is also expanding noninvasive prenatal testing access in Abu Dhab
- Illumina staff are involved in a fundraising milestone for Pedal the Cause, supporting cancer research.
Comments
Post a Comment